Edotecarin Completed Phase 2 Trials for Breast Neoplasms / Metastatic Cancer Treatment

Back to Edotecarin
IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00067314Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy